molecular function |
| GO:0003677 | | DNA binding | | Any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid). |
| GO:0001102 | | RNA polymerase II activating transcription factor binding | | Interacting selectively and non-covalently with an RNA polymerase II transcription activating factor, a protein involved in positive regulation of transcription. |
| GO:0000979 | | RNA polymerase II core promoter sequence-specific DNA binding | | Interacting selectively and non-covalently with the regulatory region composed of the transcription start site and binding sites for transcription factors of the RNA polymerase II basal transcription machinery. |
| GO:0001085 | | RNA polymerase II transcription factor binding | | Interacting selectively and non-covalently with an RNA polymerase II transcription factor, any protein required to initiate or regulate transcription by RNA polymerase II. |
| GO:0046872 | | metal ion binding | | Interacting selectively and non-covalently with any metal ion. |
| GO:0003676 | | nucleic acid binding | | Interacting selectively and non-covalently with any nucleic acid. |
| GO:0005515 | | protein binding | | Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules). |
| GO:0008134 | | transcription factor binding | | Interacting selectively and non-covalently with a transcription factor, any protein required to initiate or regulate transcription. |
| GO:0001078 | | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding | | Interacting selectively and non-covalently with a sequence of DNA that is in cis with and relatively close to a core promoter for RNA polymerase II (RNAP II) in order to stop, prevent, or reduce the frequency, rate or extent of transcription from an RNA polymerase II promoter. |
biological process |
| GO:0002295 | | T-helper cell lineage commitment | | The process in which a CD4-positive, alpha-beta T cell becomes committed to becoming a T-helper cell, a CD4-positive, alpha-beta T cell specialized to promote various immunological processes. |
| GO:0060413 | | atrial septum morphogenesis | | The developmental process in which atrial septum is generated and organized. The atrial septum separates the upper chambers (the atria) of the heart from one another. |
| GO:0003181 | | atrioventricular valve morphogenesis | | The process in which the structure of the atrioventricular valve is generated and organized. |
| GO:0007596 | | blood coagulation | | The sequential process in which the multiple coagulation factors of the blood interact, ultimately resulting in the formation of an insoluble fibrin clot; it may be divided into three stages: stage 1, the formation of intrinsic and extrinsic prothrombin converting principle; stage 2, the formation of thrombin; stage 3, the formation of stable fibrin polymers. |
| GO:0055008 | | cardiac muscle tissue morphogenesis | | The process in which the anatomical structures of cardiac muscle tissue are generated and organized. |
| GO:0060318 | | definitive erythrocyte differentiation | | Erythrocyte differentiation which occurs as part of the process of definitive hemopoiesis. |
| GO:0035162 | | embryonic hemopoiesis | | The stages of blood cell formation that take place within the embryo. |
| GO:0030218 | | erythrocyte differentiation | | The process in which a myeloid precursor cell acquires specializes features of an erythrocyte. |
| GO:0030851 | | granulocyte differentiation | | The process in which a myeloid precursor cell acquires the specialized features of a granulocyte. Granulocytes are a class of leukocytes characterized by the presence of granules in their cytoplasm. These cells are active in allergic immune reactions such as arthritic inflammation and rashes. This class includes basophils, eosinophils and neutrophils. |
| GO:0007507 | | heart development | | The process whose specific outcome is the progression of the heart over time, from its formation to the mature structure. The heart is a hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood. |
| GO:0048872 | | homeostasis of number of cells | | Any biological process involved in the maintenance of the steady-state number of cells within a population of cells. |
| GO:0035855 | | megakaryocyte development | | The process whose specific outcome is the progression of a megakaryocyte cell over time, from its formation to the mature structure. Megakaryocyte development does not include the steps involved in committing a cell to a megakaryocyte fate. A megakaryocyte is a giant cell 50 to 100 micron in diameter, with a greatly lobulated nucleus, found in the bone marrow. |
| GO:0030219 | | megakaryocyte differentiation | | The process in which a myeloid precursor cell acquires specializes features of a megakaryocyte. |
| GO:0003192 | | mitral valve formation | | The developmental process pertaining to the initial formation of the mitral valve from unspecified parts. This process begins with the specific processes that contribute to the appearance of the discrete structure and ends when the structural rudiment is recognizable. |
| GO:0045599 | | negative regulation of fat cell differentiation | | Any process that stops, prevents, or reduces the frequency, rate or extent of adipocyte differentiation. |
| GO:0045403 | | negative regulation of interleukin-4 biosynthetic process | | Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of interleukin-4. |
| GO:0060377 | | negative regulation of mast cell differentiation | | Any process that decreases the rate, frequency or extent of mast cell differentiation, the process in which a relatively unspecialized myeloid precursor cell acquires the specialized features of a mast cell. A mast cell is a cell that is found in almost all tissues containing numerous basophilic granules and capable of releasing large amounts of histamine and heparin upon activation. |
| GO:0032091 | | negative regulation of protein binding | | Any process that stops, prevents, or reduces the frequency, rate or extent of protein binding. |
| GO:0000122 | | negative regulation of transcription from RNA polymerase II promoter | | Any process that stops, prevents, or reduces the frequency, rate or extent of transcription from an RNA polymerase II promoter. |
| GO:0003151 | | outflow tract morphogenesis | | The process in which the anatomical structures of the outflow tract are generated and organized. The outflow tract is the portion of the heart through which blood flows into the arteries. |
| GO:0030220 | | platelet formation | | The process in which platelets bud from long processes extended by megakaryocytes. |
| GO:0045078 | | positive regulation of interferon-gamma biosynthetic process | | Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of interferon-gamma. |
| GO:0045944 | | positive regulation of transcription from RNA polymerase II promoter | | Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter. |
| GO:0060319 | | primitive erythrocyte differentiation | | Erythrocyte differentiation which occurs as part of the process of primitive hemopoiesis. |
| GO:0032642 | | regulation of chemokine production | | Any process that modulates the frequency, rate, or extent of chemokine production. |
| GO:0010724 | | regulation of definitive erythrocyte differentiation | | Any process that modulates the rate, frequency, or extent of definitive erythrocyte differentiation. Definitive erythrocyte differentiation occurs as part of the process of definitive hemopoiesis. |
| GO:0006355 | | regulation of transcription, DNA-templated | | Any process that modulates the frequency, rate or extent of cellular DNA-templated transcription. |
| GO:0006351 | | transcription, DNA-templated | | The cellular synthesis of RNA on a template of DNA. |
| GO:0071733 | | transcriptional activation by promoter-enhancer looping | | The formation and maintenance of DNA loops that juxtapose the promoter and enhancer regions of RNA polymerase II-transcribed genes and activate transcription from an RNA polymerase II promoter. |
| GO:0003195 | | tricuspid valve formation | | The developmental process pertaining to the initial formation of the tricuspid valve from unspecified parts. This process begins with the specific processes that contribute to the appearance of the discrete structure and ends when the structural rudiment is recognizable. |
| GO:0060412 | | ventricular septum morphogenesis | | The developmental process in which a ventricular septum is generated and organized. A ventricular septum is an anatomical structure that separates the lower chambers (ventricles) of the heart from one another. |
cellular component |
| GO:0005737 | | cytoplasm | | All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
| GO:0005654 | | nucleoplasm | | That part of the nuclear content other than the chromosomes or the nucleolus. |
| GO:0005634 | | nucleus | | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. |
| GO:0005667 | | transcription factor complex | | A protein complex that is capable of associating with DNA by direct binding, or via other DNA-binding proteins or complexes, and regulating transcription. |
| GO:0017053 | | transcriptional repressor complex | | A protein complex that possesses activity that prevents or downregulates transcription. |